Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Cephalosporin Drugs Market - 2024-2031
US$ 3,400.00
Cephalosporin Drugs Marketis is growing with a CAGR of 2.60% during the forecast period 2026-2035. The Cephalosporin Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
February 2026
45 pages
Addison’s Disease Market - 2024-2031
US$ 3,400.00
Addison’s Disease Marketis is growing with a CAGR of 10.00% during the forecast period 2026-2035. The Addison’s Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...
February 2026
43 pages
Bisphosphonates Market - 2024-2031
US$ 3,400.00
Bisphosphonates Marketis is growing with a CAGR of 3.70% during the forecast period 2026-2035. The Bisphosphonates Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...
February 2026
41 pages
Europe Liver Disease Treatment Market - 2024-2031
US$ 2,499.00
Europe Liver Disease Treatment Market reached in and is expected to reach by , growing with a CAGR of 11.56% during the forecast period 2026-. The Europe Liver Disease Treatment Market emerges as a ke...
February 2026
56 pages
Fanconi Anemia Market - 2024-2031
US$ 3,400.00
The Fanconi Anemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
February 2026
40 pages
Peptide Cancer Vaccine Market - 2024-2031
US$ 3,400.00
Peptide Cancer Vaccine Marketis is growing with a CAGR of 21.32% during the forecast period 2026-2035. The Peptide Cancer Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth an...
February 2026
48 pages
Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceutical Industry, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2026-2034
US$ 2,999.00
The global medical cannabis market size reached USD 39.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 74.3 Billion by 2034, exhibiting a growth rate (CAGR) of 6.90% du...
February 2026
150 pages
Active Pharmaceutical Ingredients (API) Market Size, Share, Trends and Forecast by Drug Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, and Region, 2026-2034
US$ 2,999.00
The global active pharmaceutical ingredients (API) market size was valued at USD 256.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 376.2 Billion by 2034, exhibiting...
February 2026
141 pages
